Cerdelga® (eliglustat) Official Healthcare Professional Site
CERDELGA is the only first-line oral therapy indicated for treating most adults with Gaucher disease type 1.
Cerdelga® (eliglustat) Official Patient Site
CERDELGA is a prescription medicine used for the long-term treatment of Gaucher disease type 1 (GD1) in adults who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers …
Downloadable Resources - Cerdelga
CERDELGA is indicated for the long-term treatment of adult patients with Gaucher disease type 1 (GD1) who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or …
Cerdelga® (eliglustat) capsules - sanofi.us
<ul> <li><a href="https://products.sanofi.us/cerdelga/cerdelga.pdf" target="_blank">Prescribing Information</a></li> <li><a href="https://products.sanofi.us/cerdelga ...
Sanofi - Products - Specialty Care - CERDELGA® (eliglustat)
CERDELGA® (eliglustat) is indicated for the long-term treatment of adult patients with Gaucher disease type 1 (GD1) who are CYP2D6 extensive metabolizers (EMs), intermediate …
Support and Resources - Cerdelga
CERDELGA is a prescription medicine used for the long-term treatment of Gaucher disease type 1 (GD1) in adults who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers …
CERDELGA® (ELIGLUSTAT)
Cerdelga® (eliglustat) is the only first-line oral therapy indicated for the long-term treatment of most adults with Gaucher disease type 1. Learn more about Cerdelga® (eliglustat).
Cerdelga® - Sanofi
<p>(eliglustat)</p>
CERDELGA - GNH USA
Eliglustat works by blocking an enzyme involved in the production of glucosylceramide, a fatty substance that builds up in the body of people with Gaucher disease. Cerdelga is typically …
Cerdelga® (eliglustat) Capsules | Patient Support Services
Find resources to support eligible adults who are prescribed Cerdelga through the CareConnect program.
- Some results have been removed